Reports

Ideas That Generate Results

List of Figures:

Figure 5-1: Global - Liquid Biopsy Market (Million US$), 2015 & 2020
Figure 6-1: Global - Liquid Biopsy Market by Technology (%), 2015
Figure 6-2: Global - Liquid Biopsy Market for CTCs (Million US$), 2015 & 2020
Figure 6-3: Global - Liquid Biopsy Market for ctDNA (Million US$), 2015 & 2020
Figure 6-4: Global - Liquid Biopsy Market for Exosomes (Million US$), 2015 & 2020
Figure 7-1: Global - Liquid Biopsy Market by Sample Type (%), 2015
Figure 7-2: Global - Blood Based Liquid Biopsy Market (Million US$), 2015 & 2020
Figure 7-3: Global - Urine Based Liquid Biopsy Market (Million US$), 2015 &2020
Figure 8-1: Global - Liquid Biopsy Market by Geography (%), 2015
Figure 8-2: North America - Liquid Biopsy Market (Million US$), 2015 & 2020
Figure 8-3: Europe - Liquid Biopsy Market (Million US$), 2015 & 2020
Figure 8-4: Asia - Liquid Biopsy Market (Million US$), 2015 & 2020
 
List of Tables:

Table 4-1: Global - Cancer Incidence by Region (Million), 2020
Table 4-2: Comparison of the Analysis Capability of CTC's, cfDNA and Exosomes
Table 8-1: North America - Cancer Incidences by Type ('000), 2015 & 2020
Table 8-2: Europe - Cancer Incidences by Type ('000), 2015 & 2020
Table 8-3: Asia - Cancer Incidences by Type ('000), 2015 & 2020
Table 9-1: Pipeline Analysis for Liquid Biopsy
Table 10-1: Personal Genome Diagnostics - Liquid Biopsy Associated Product Line
Table 10-2: Guardant Health - Liquid Biopsy Associated Product Line
Table 10-3: Pathway Genomics - Liquid Biopsy Associated Product Line
Table 10-4: NeoGenomics, Inc. - Key Financials (Million US$), 2012-2014
Table 10-5: NeoGenomics - Liquid Biopsy Associated Product Line
Table 10-6: RainDance Technologies - Key Financials (Million US$), 2012-2014
Table 10-7: RainDance Technology - Liquid Biopsy Associated Product Line
Table 10-8: Trovagene - Key Financials (Million US$), 2013-2015
Table 10-9: Trovagene - Liquid Biopsy Associated Product Line
Table 10-10: Circulogene Theranostics - Liquid Biopsy Associated Product Line
Table 10-11: Biocartis Group NV - Key Financials (Million US$), 2012-2014
Table 10-12: Biocartis - Liquid Biopsy Associated Product Line
Table 10-13: Cynvenio Biosystems, Inc. - Liquid Biopsy Associated Product Line
Table 10-14: Biocept, Inc. - Key Financials (Million US$), 2012-2014
Table 10-15: Biocept, Inc. - Liquid Biopsy Associated Product Line
Table 10-16: ANGLE plc - Key Financials (Million US$), 2013-2015
Table 10-17: ANGLE plc - Liquid Biopsy Associated Product Line
Table 10-18: MDxHealth - Key Financials (Million US$), 2012-2014
Table 10-19: MDxHealth - Liquid Biopsy Associated Product Line
Table 10-20: Clearbridge BioMedics Pte Ltd - Liquid Biopsy Associated Product Line
Table 10-21: Exosome Diagnostics, Inc. - Liquid Biopsy Associated Product Line